This equity-for-services swap is a red flag for a micro-cap with no recent financials filed. Traders should expect continued dilution pressure and monitor for further cash-burn disclosures. The restricted share legend limits immediate selling, but the overhang will weigh on the stock until the services are fully delivered or the shares become eligible for resale under Rule 144.
Price Chart
Executive Summary
BioForce Nanosciences issued 4,516,909 restricted shares of common stock in a private placement to pay for services valued at $2,484,300. This is a significant dilutive event for a micro-cap OTC stock, effectively paying for expenses with equity rather than cash, which signals cash constraints and weakens existing shareholder value. The filing is bearish due to the material dilution without any corresponding cash inflow.
Key Financial Metrics
Key Facts
- Issued 4,516,909 restricted shares of common stock on August 31, 2026.
- Shares were issued for services valued at $2,484,300 in a private placement under Section 4(2).
- No commissions or fees were paid in connection with the sale.
- Shares are restricted and bear a Rule 144 legend, limiting immediate resale.
- CEO/CFO Richard Kaiser signed the filing, indicating insider knowledge of the transaction.
Financial Impact
Dilution of approximately 4.5M shares for $2.48M in services; no cash raised. The implied price per share is roughly $0.55, but the stock trades on OTC with low liquidity, making the effective dilution to existing holders significant.
Risk Factors
- Continued dilution from additional equity issuances to fund operations.
- Potential cash crunch if the company cannot raise capital on better terms.
- Low liquidity on OTC markets amplifies price impact from any selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (BFNH) — Batch item 1 | 0001091818-26-000140 |
| Document: 0001091818-26-000140-index-headers.html | 0001091818-26-000140 |
| Document: 0001091818-26-000140-index.html | 0001091818-26-000140 |
| Document: 0001091818-26-000140.txt | 0001091818-26-000140 |
| 8-K Filing (BFNH) — Batch item 5 | 0001091818-26-000140 |
| Document: 0001091818-26-000140-index-headers.html | 0001091818-26-000140 |
| Document: 0001091818-26-000140-index.html | 0001091818-26-000140 |
| Document: 0001091818-26-000140.txt | 0001091818-26-000140 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | 8-K | $8.89 | awaiting T+20 | — | $7.95 (−10.57%) |
Sep 4, 2026 7w ago | 8-K | $6.10 $7.01 | ▼ −14.92% | ▼ −14.07% | $7.95 (−30.33%) |
Aug 18, 2026 9w ago | 8-K | $3.84 $10.01 | ▲ +160.68% | ▲ +161.67% | $7.95 (+107.03%) |
Aug 14, 2026 10w ago | 8-K | $3.40 $9.71 | ▲ +185.59% | ▲ +187.58% | $7.95 (+133.82%) |
Jul 7, 2026 15w ago | 8-K | $2.02 $1.85 | ▼ −8.42% | ▼ −11.57% | $7.95 (+293.56%) |
Jul 1, 2026 16w ago | 8-K | $1.69 $1.90 | ▲ +12.43% | ▲ +12.97% | $7.95 (+370.41%) |
Jun 18, 2026 18w ago | 8-K | $1.79 $1.50 | ▼ −16.20% | ▼ −15.58% | $7.95 (+344.13%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers